HomePeptide encyclopedia › KPV

KPV: what it is and what the evidence says

A peptide fragment studied for its relationship with inflammation modulation, especially at the gut level.

Immune Preclinical evidence only 6 verified references No dosages
PX PeptiXtreme editorial team · Grupo VidaXtreme
Last reviewed: August 16, 2026 · How we verify this
How to read this page. It is written so you can check it: every claim about evidence hangs from a reference with its PubMed identifier, and we state just as plainly what is known and what is not. You will not find dosages or protocols anywhere on this site.

The ground it plays on

The immune system is not something you turn "up" or "down": it is regulated. A compound that raised the response without control would be a problem, not a benefit, which is why the correct word is modulation. For people with autoimmune or inflammatory conditions, this stops being a technical nuance.

What it is studied for

Gut health, inflammation, recovery.

There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.

What the human evidence says

There is no published clinical trial of KPV in humans: all the evidence comes from animal models of colitis and from cell cultures.

The limitation that matters most

Almost every positive study uses colon-targeted delivery systems (nanoparticles, hydrogels) in rodents, so it cannot be assumed that KPV taken orally or injected in people reproduces those results.

Regulatory status

Not approved.

Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.

Cautions and context

Developing research; variable individual response.

With diagnosed digestive or inflammatory conditions, prioritize professional assessment.

This is not medical advice. Any decision about a compound in this encyclopedia belongs to a healthcare professional who knows your history, what you already take and your specific situation. If something you are using produces a new symptom, that is not something to observe — it is something to consult.

What this page cannot give you

A reference page can take you this far. You know what KPV is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:

That is what the course is for

PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.

See the course → Or measure your judgment, free

References

Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.

  1. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel diseasepreclinical Inflamm Bowel Dis · 2008 · PMID 18092346 →
  2. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationpreclinical Gastroenterology · 2008 · PMID 18061177 →
  3. Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine modelpreclinical Cell Mol Gastroenterol Hepatol · 2016 · PMID 27458604 →
  4. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitispreclinical Mol Ther · 2017 · PMID 28143741 →
  5. Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Ratspreclinical ACS Biomater Sci Eng · 2021 · PMID 34547895 →
  6. alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugsreview Ann Rheum Dis · 2007 · PMID 17934097 →

Was this page useful?

Research moves, and when something relevant changes we update the page. If you want to hear about it for KPV or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.

Frequently asked questions

What is KPV?

A peptide fragment studied for its relationship with inflammation modulation, especially at the gut level. It is studied within the area of immune.

Is there human evidence for KPV?

There is no published clinical trial of KPV in humans: all the evidence comes from animal models of colitis and from cell cultures.

Is it approved by any health agency?

Not approved.

What is the dose of KPV?

We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.

Where can I learn to evaluate this properly?

This page tells you what KPV is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.

Other immune compounds

Timosina Alfa-1Immune supportLL-37Innate defenseVIPImmune balanceThymogenAdvertised for immune modulation

← See the full encyclopedia (75 compounds)